ESR1 and breast neoplasm: In breast cancer, the presence of germline mutations in BRCA1/2 is characterized by features of basal-like sporadic breast tumors, including a greater likelihood of being high-grade, ER/PgR-negative, HER2-negative, and a high frequency of TP53 mutations [98].